Literature DB >> 3044428

Adjuvant tamoxifen for early breast cancer.

I Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3044428      PMCID： PMC2246473          DOI： 10.1038/bjc.1988.122

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  3 in total

1.  Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer.

Authors:  H Brincker; C Rose; F Rank; H T Mouridsen; A Jakobsen; P Dombernowsky; J Panduro; K W Andersen
Journal:  J Clin Oncol       Date:  1987-11       Impact factor: 44.544

2.  Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.

Authors:  J R Sainsbury; J R Farndon; G K Needham; A J Malcolm; A L Harris
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

3.  Mechanism of action of adjuvant chemotherapy in early breast cancer.

Authors:  N Padmanabhan; A Howell; R D Rubens
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321
  3 in total
  3 in total

Review 1.  Long-term adjuvant tamoxifen therapy for breast cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

Review 2.  Adjuvant chemotherapy for early breast cancer.

Authors:  I C Henderson
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

Review 3.  The future of new pure antiestrogens in clinical breast cancer.

Authors:  A E Wakeling
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.